Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravesical Instillation Therapy With Bacillus Calmette-Guérin (BCG) and Sequential BCG and Electromotive Mitomycin-C (EMDA-MCC) in Patients With High-risk Non-muscle-invasive Bladder Carcinoma

NCT03664869 is registered in ClinicalTrials.gov with Turku University Hospital as lead sponsor.

NCT NCT03664869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03664869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravesical Instillation Therapy With Bacillus Calmette-Guérin (BCG) and Sequential BCG and Electromotive Mitomycin-C (EMDA-MCC) in Patients With High-risk Non-muscle-invasive Bladder Carcinoma
Lead sponsor
Turku University Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
October 26, 2018
Completion date
November 1, 2025
Enrollment
300 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer